| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.24 | 1e-12 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.21 | 3e-10 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.19 | 7e-09 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | -0.18 | 5e-08 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.19 | 8e-08 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.17 | 9e-08 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.17 | 1e-07 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | -0.19 | 2e-07 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.17 | 2e-07 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.17 | 2e-07 |